Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Karl Odquist

Premium

Pathway Genomics has appointed Karl Odquist as executive director of managed care. Odquist will be based out of Pathway's San Diego, Calif., headquarters and be in charge of managed care contracting, reimbursement, government affairs, and clinical evidence generation for the firm's diagnostic services division.

Odquist brings to Pathway more than 20 years of experience working with payors in the life sciences field. Before joining Pathway, he held various leadership positions at a number of drug and diagnostics companies, including Prometheus Laboratories.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.